Global Aptamers Market Research Report

As per the research conducted by GME, the Global Aptamers Market will grow with a CAGR value of 15.5% percent. The factors driving the growth of this market are the increasing usage of aptamers in fields such as research, diagnostics, industrial, and medicine. Cost effectiveness too plays a major role in supporting the market demand for Aptamers. Increasing research activities in the pharmacy and biotechnology industries and rising government expenditure to support the research activities will support the market grow from 2021 to 2026. Furthermore, rapid rise in the infection related cases across the globe along with increasing geriatric patient population, the market will grow exponentially.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Aptamers Market - Forecast to 2026”

https://www.globalmarketestimates.com/market-report/global-aptamers-market-3194

By Type (Nucleic Acid and Peptide), By Application (Diagnostics, Therapeutics, Research & Developments, and Others) By Region (North America, Asia Pacific, CSA, Europe, and The Middle East and Africa); End-User, Landscape, Company Market Share Analysis, and Competitor Analysis

Key Market Insights

Aptamers are single-stranded short DNA or RNA molecules that can selectively bind to specific targets such as peptides, proteins, small molecules, carbohydrates, live cells and toxins.
They are flexible and block areas with high selectivity. Their binding is characterized by tertiary structure and not primary design.
Increasing number of infectious diseases and COVID-19 cases in the Asia Pacific region will help the market grow rapidly
The nucleic acid segment is the leading segment as it has a widespread use in applications such as cancer diagnostics, disease diagnosis, drug delivery research, and non-immunogenic research
Aptamers are in high demand for molecular imaging, biomarker discovery, and other diagnostic applications, which has fuelled the growth of diagnostic segment
Aptagen, AM Biotechnologies, Aptabiosciences, Aptitude Medical Systems Inc., Altermune LLC, DSM Biotechnology, Izon Science Oxford, Ophthotech, SomaLogic, NoxxonPharma AG, Gilead Sciences Inc., AptSci Inc., AptaMatrix, Base Pair Biotechnologies, NeoVentures Biotechnology Inc., among others are the top players in the Aptamers Market
In March 2021, Aptamer Group the developer of Optimer reagents announced its merger with Mologic, which is a manufacturer of lateral flow and rapid diagnostic test kits. The merger was executed with an aim to manufacture testing kits for Novel Coronavirus i.e. SARS-CoV-2.

Browse the Report @https://www.globalmarketestimates.com/market-report/global-aptamers-market-3194

Type Outlook (Revenue, USD Billion, 2021-2026)